Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath

NCT06528418 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-03-26

No results posted yet for this study

Summary

The goal of this observational study is to develop an advanced expiratory algorithm model utilizing exhaled breath volatile organic compound (VOC) marker molecules. This model aims to accurately diagnose mutiple pulmonary diseases. The primary objectives it strives to accomplish are:

1. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose several common pulmonary diseases.
2. To assess the diagnostic accuracy of an exhaled breath VOC-assisted diagnostic artificial intelligence (AI) model in diagnose more pulmonary diseases.

Conditions

Interventions

OTHER

Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system

Exhaled breath samples from these participants will be collected and analyzed to detect volatile organic compound molecules in human exhaled breath by GC-MS and μGC-PID

Sponsors & Collaborators

  • The First Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • First People's Hospital of Foshan

    collaborator OTHER
  • Sichuan Cancer Hospital and Research Institute

    collaborator OTHER
  • Liwan District Central Hospital

    collaborator UNKNOWN
  • Shanghai Chest Hospital

    collaborator OTHER
  • Peking Union Medical College Hospital

    collaborator OTHER
  • Guangzhou Development Zone Hospital

    collaborator UNKNOWN
  • Huangpu District Hongshan Street Community Health Service Center

    collaborator UNKNOWN
  • Huangpu District Chinese Medicine Hospital

    collaborator UNKNOWN
  • Fifth Affiliated Hospital of Guangzhou Medical University

    collaborator OTHER
  • Huangpu District Jiufo Street Community Health Service Center

    collaborator UNKNOWN
  • Huangpu District Xinlong Town Central Hospital

    collaborator UNKNOWN
  • Huangpu District Yonghe Street Community Health Service Center

    collaborator UNKNOWN
  • Huangpu District Lianhe Street Second Community Health Service Center

    collaborator UNKNOWN
  • ChromX Health

    lead INDUSTRY

Principal Investigators

  • Jianxing He, MD · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-06-30
Primary Completion
2026-12-30
Completion
2027-06-30

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06528418 on ClinicalTrials.gov